Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
Oncotarget|April 11, 2015
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cellsMoitza Principe, Patrizia Ceruti, Neng-Yao Shih, et al.Frontiers in Immunology|August 23, 2024
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigensSilvia Brugiapaglia, Sara Bulfamante, Claudia Curcio, et al.Neurology(R) Neuroimmunology & Neuroinflammation|January 29, 2016
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 monthsStefania De Mercanti, Simona Rolla, Angele Cucci, et al.Frontiers in Immunology|March 17, 2022
Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-UpSimona Rolla, Stefania Federica De Mercanti, Valentina Bardina, et al.Journal of Experimental & Clinical Cancer Research : CR|June 2, 2024
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancerClaudia Curcio, Gianluca Mucciolo, Cecilia Roux, et al.Journal for Immunotherapy of Cancer|October 29, 2020
In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccinationGiorgia Mandili, Claudia Curcio, Sara Bulfamante, et al.Gastroenterology|December 19, 2021
Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and PancreatitisAndrea Costamagna, Dora Natalini, Maria Del Pilar Camacho Leal, et al.EMBO Molecular Medicine|June 27, 2018
Soluble stroma-related biomarkers of pancreatic cancerAndrea Resovi, Maria Rosa Bani, Luca Porcu, et al.Cancers|April 5, 2020
Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer PatientsGiorgia Mandili, Laura Follia, Giulio Ferrero, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2012
Th17 cells in multiple sclerosis express higher levels of JAK2, which increases their surface expression of IFN-γR2Laura Conti, Raffaele De Palma, Simona Rolla, et al.Pageof 11